Hospital Pharmacy and Critical Care Medicine: a necessary alliance

by María Cruz Martin-Delgado, Miguel Ángel Calleja-Hérnandez
Published 2018-09-01

MAPEX: look deeper, looking away

by Ramón Morillo Verdugo, Javier Sáez de la Fuente, Miguel Ángel Calleja Hernandez
Published 2015-07-01

Development of integrated support software for clinical nutrition

by Pedro Siquier Homar, Manel Pinteño Blanco, Miguel Ángel Calleja Hernández, Francisco Fernández Cortés, Jesús Martínez Sotelo
Published 2015-09-01

Trends in endpoint selection and result interpretation in advanced non‐small cell lung cancer clinical trials published between 2000 and 2012: A retrospective cohort study

by Cristina Fernández‐López, Miguel Ángel Calleja‐Hernández, Jaime Espín Balbino, José Cabeza‐Barrera, José Expósito‐Hernández
Published 2019-04-01

A new definition and refocus of pharmaceutical care: the Barbate Document

by Ramón Morillo-Verdugo, José Luis Poveda-Andrés, María de las Aguas Robustillo-Cortés, Miguel Ángel Calleja-Hernández
Published 2020-07-01

Pharmacist recommendations for carbapenem de-escalation in urinary tract infection within an antimicrobial stewardship program

by Svetlana Sadyrbaeva-Dolgova, Pilar Aznarte-Padial, Alberto Jimenez-Morales, Manuela Expósito-Ruiz, Miguel Ángel Calleja-Hernández, Carmen Hidalgo-Tenorio
Published 2020-04-01

Clinical outcomes of carbapenem de-escalation regardless of microbiological results: A propensity score analysis

by Svetlana Sadyrbaeva-Dolgova, Pilar Aznarte-Padial, Juan Pasquau-Liaño, Manuela Expósito-Ruiz, Miguel Ángel Calleja Hernández, Carmen Hidalgo-Tenorio
Published 2019-08-01

SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain’s hospital pharmacy departments

by Montserrat Pérez-Encinas, Ana Lozano-Blázquez, Javier García-Pellicer, Inmaculada Torre-Lloveras, José Luis Poveda-Andrés, Miguel Ángel Calleja-Hernández
Published 2020-11-01

2019 SEFH National Survey: service portfolio, care activities, education and research in Spain’s hospital pharmacy departments

by Montserrat Pérez-Encinas, Ana Lozano-Blázquez, Javier García-Pellicer, Inmaculada Torre-Lloveras, José Luis Poveda-Andrés, Miguel Ángel Calleja-Hernández
Published 2021-01-01

Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement

by Miguel Ángel Calleja Hernández, Alicia Herrero Ambrosio, María Jesús Lamas Díaz, Julio Martínez Cutillas, Jose Luis Poveda Andrés, Belén Aragón
Published 2017-01-01

Effectiveness and safety of pemetrexed for non-small cell lung cancer in the Andalusian Public Health System

by María Antonia Pérez-Moreno, Jesús Cotrina-Luque, Mercedes Galván-Banqueri, Sandra Flores-Moreno, Francisco Javier Bautista-Paloma, Miguel Ángel Calleja-Hernández
Published 2016-11-01

Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH

by Ruth Vera, José Palacios, Xavier Matías-Guiu, Miguel Martín, María Jesús Lamas, Enrique de Álava, Miguel Ángel Calleja, Azucena Aldaz, Pilar Garrido
Published 2017-11-01

Asociación entre el síndrome coronario agudo y el consumo de antiinflamatorios no esteroideos

by José Luis Sánchez Serrano, José María Tenias Burillo, María Isabel Chinchilla Fernández, Laura Jiménez López, Antonio Padilla Serrano, Miguel Ángel Calleja Hernández
Published 2015-01-01

DPYD variant testing in candidates for fluoropyrimidine treatment: A study protocol

by Ana Hernández-Guío, M.ª Ángeles Bernabéu-Martínez, Andrés Corno-Caparrós, M.ª Teresa Aznar-Saliente, Manuel Bonete-Sánchez, Miguel Ángel Calleja-Hernández
Published 2021-05-01

Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis

by María José Zarzuelo Romero, Cristina Pérez Ramírez, María Isabel Carrasco Campos, Almudena Sánchez Martín, Miguel Ángel Calleja Hernández, María Carmen Ramírez Tortosa, Alberto Jiménez Morales
Published 2021-04-01

The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner in colon and breast cancer cells.

by María Angel García, Esther Carrasco, Margarita Aguilera, Pablo Alvarez, Carmen Rivas, Joaquin María Campos, Jose Carlos Prados, Miguel Angel Calleja, Mariano Esteban, Juan Antonio Marchal, Antonia Aránega
Published 2011-01-01

Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System

by Joaquín Dopazo, Douglas Maya-Miles, Federico García, Nicola Lorusso, Miguel Ángel Calleja, María Jesús Pareja, José López-Miranda, Jesús Rodríguez-Baño, Javier Padillo, Isaac Túnez, Manuel Romero-Gómez
Published 2021-05-01

Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Phar...

by Silvia Valero-García, Eva González-Haba, Maria Queralt Gorgas-Torner, José María Alonso-Herreros, Ana Cristina Cercós Lletí, José Luis Poveda-Andrés, Miguel Ángel Calleja-Hernandez, Olga Delgado-Sánchez
Published 2021-03-01

A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)

by Fernando de Andrés-Nogales, Encarnación Cruz, Miguel Ángel Calleja, Olga Delgado, Maria Queralt Gorgas, Jaime Espín, Jorge Mestre-Ferrándiz, Francesc Palau, Alba Ancochea, Rosabel Arce, Raquel Domínguez-Hernández, Miguel Ángel Casado, the FinMHU-MCDA Group
Published 2021-04-01

Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: Costecat Study

by Ana Rosa Rubio-Salvador, Vicente Escudero-Vilaplana, José Antonio Marcos Rodríguez, Irene Mangues-Bafalluy, Beatriz Bernárdez Ferrán, Carlos García Collado, Roberto Collado-Borrell, María Dolores Alvarado Fernández, José Ignacio Chacón López-Muñiz, María Yébenes Cortés, Manuel Gómez Barrera, Miguel Ángel Calleja-Hernández
Published 2021-01-01